Related references
Note: Only part of the references are listed.The therapeutic efficacy and safety of intravenous immunoglobulin in dermatomyositis and polymyositis: A systematic review and meta-analysis
Anji Xiong et al.
MODERN RHEUMATOLOGY (2023)
Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
Laia Alsina et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2022)
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis
Rudra Prosad Goswami et al.
AUTOIMMUNITY REVIEWS (2022)
Role of Intravenous Immunoglobulin in Necrotizing Autoimmune Myopathy
Amanda Kocoloski et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2022)
Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis
Li-Mei Wang et al.
RHEUMATOLOGY (2022)
Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review
Mark McPherson et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2022)
Trial of Intravenous Immune Globulin in Dermatomyositis
R. Aggarwal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry Study
Kuan Liu et al.
JOURNAL OF RHEUMATOLOGY (2021)
Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study
Johan Lim et al.
RHEUMATOLOGY (2021)
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study
Simone Barsotti et al.
AUTOIMMUNITY REVIEWS (2021)
Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis (ProDERM Study)
Rohit Aggarwal et al.
MEDICINE (2021)
Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients
Julie J. Paik et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Dermatomyositis requires long-term treatment with combined immunosuppressive and immunoglobulin therapy
Antonia Wiala et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2021)
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
Marinos C. Dalakas
NEUROTHERAPEUTICS (2021)
Initial predictors for short-term prognosis in anti-melanoma differentiation-associated protein-5 positive patients
Qihua Yang et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
The Cost Effectiveness of Immunoglobulin vs. Hematopoietic Stem Cell Transplantation for CIDP
Richard K. Burt et al.
FRONTIERS IN NEUROLOGY (2021)
A North American Cohort of Anti-SAE Dermatomyositis: Clinical Phenotype, Testing, and Review of Cases
Jemima Albayda et al.
ACR OPEN RHEUMATOLOGY (2021)
Management of Myositis-Associated Interstitial Lung Disease
Tomoyuki Fujisawa
MEDICINA-LITHUANIA (2021)
Pregnancy in myositis and scleroderma
Sirajum Munira et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems
Maria Giovanna Danieli et al.
AUTOIMMUNITY REVIEWS (2020)
Pregnancy outcomes in women with idiopathic inflammatory myopathy, before and after diagnosis-a population-based study
Weng Ian Che et al.
RHEUMATOLOGY (2020)
Anti-MDA5-associated dermatomyositis
Rajiv Gupta et al.
INTERNAL MEDICINE JOURNAL (2020)
Immune-mediated necrotizing myopathy: clinical features and pathogenesis
Yves Allenbach et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
MDA-5 dermatomyositis complicated by interstitial lung disease and cutaneous ulcers: successful treatment with corticosteroids, mycophenolate mofetil and intravenous immunoglobulin
Kelli Stager et al.
BMJ CASE REPORTS (2020)
The Value of Intravenous Immunoglobulin Therapy in Idiopathic Inflammatory Myositis in the Current Transformed Era of Biologics
Anjali Patwardhan
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease
J. A. Huapaya et al.
RESPIRATORY MEDICINE (2019)
The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan
Naoki Suzuki et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Autoimmune Myopathies: Updates on Evaluation and Treatment
Emer R. McGrath et al.
NEUROTHERAPEUTICS (2018)
Severe Recurrent Necrotizing Myopathy in Pregnancy: A Case Report
Yue Li et al.
FRONTIERS IN NEUROLOGY (2018)
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
Anna Tjarnlund et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Anaphylaxis to IVIG
Sharon Julie Williams et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2017)
Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management
R. Yazdani et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)
EFFICACY OF INTRAVENOUS IMMUNOGLOBULIN THERAPY IN REFRACTORY DYSPHAGIA IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES
M. Giannini et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Intravenous immunoglobulin contributes to the control of antimelanoma differentiation-associated protein 5 antibody-associated dermatomyositis with palmar violaceous macules/papules
H. Koguchi-Yoshioka et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Rapidly Progressive Interstitial Lung Disease Associated with Dermatomyositis Treated with Combination of Immunosuppressive Therapy, Direct Hemoperfusion with a Polymyxin B Immobilized Fiber Column and Intravenous Immunoglobulin
Motohisa Takai et al.
INTERNAL MEDICINE (2015)
Intravenous immunoglobulin for treatment of dermatomyositis-associated dystrophic calcinosis
Fabrizio Galimberti et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Intravenous immunoglobulin in neurology-mode of action and clinical efficacy
Jan D. Luenemann et al.
NATURE REVIEWS NEUROLOGY (2015)
Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy
Andrew L. Mammen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Cost-Utility Analysis of Intravenous Immunoglobulin for the Treatment of Steroid-Refractory Dermatomyositis in Thailand
Naruemon Bamrungsawad et al.
PHARMACOECONOMICS (2015)
High-dose intravenous immunoglobulin therapy for rapidly progressive interstitial pneumonitis accompanied by anti-melanoma differentiation-associated gene 5 antibody-positive amyopathic dermatomyositis
Kazu Hamada-Ode et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2015)
Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy
Sudarshini Ramanathan et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases
Patrick Cherin et al.
CASE REPORTS IN NEUROLOGY (2015)
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis
Maria Giovanna Danieli et al.
CLINICAL RHEUMATOLOGY (2014)
A Comparison Of Costs Between Outpatient Hospital, Clinic and Home Settings For Intravenous Immunoglobulin (IVIG) Infusions
Xiaolan Ye et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Clinical efficacy of intravenous immunoglobulins for the treatment of dermatomyositis skin lesions without muscle disease
T. Bounfour et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Improvement in lung fibrosis using intravenous immunoglobulin in systemic sclerosis with myositis
W. Mauhin et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2014)
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis A Randomized, Placebo-Phase Trial
Chester V. Oddis et al.
ARTHRITIS AND RHEUMATISM (2013)
Intravenous immunoglobulin for refractory cutaneous dermatomyositis: A retrospective analysis from an academic medical center
Alisa N. Femia et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
SUBCUTANEOUS IMMUNOGLOBULIN TREATMENT OF INCLUSION-BODY MYOSITIS STABILIZES DYSPHAGIA
Kaweh Pars et al.
MUSCLE & NERVE (2013)
Adverse Effects of Human Immunoglobulin Therapy
E. Richard Stiehm
TRANSFUSION MEDICINE REVIEWS (2013)
Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome
Isabelle Marie et al.
ARTHRITIS RESEARCH & THERAPY (2013)
A 79-Year-Old Man With Dyspnea, Dysphagia, and Weakness
Mar Riveiro-Barciela et al.
CHEST (2012)
Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial
Nobuyuki Miyasaka et al.
MODERN RHEUMATOLOGY (2012)
Treatment of inclusion body myositis: is low-dose intravenous immunoglobulin the solution?
Mike Recher et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Morbidity and Mortality in Adult Polymyositis and Dermatomyositis
Isabelle Marie
CURRENT RHEUMATOLOGY REPORTS (2012)
Polymyositis Associated With Severe Interstitial Lung Disease Remission After Three Doses of IV Immunoglobulin
Catherine J. Bakewell et al.
CHEST (2011)
Intravenous immunoglobulin treatment for pregnancy-associated dermatomyositis
Garifallia Linardaki et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Mechanisms of Action of Intravenous Immunoglobulin in Inflammatory Muscle Disease
Adam Quick et al.
CURRENT RHEUMATOLOGY REPORTS (2011)
Intravenous Immunoglobulins for Steroid-Refractory Esophageal Involvement Related to Polymyositis and Dermatomyositis: A Series of 73 Patients
I. Marie et al.
ARTHRITIS CARE & RESEARCH (2010)
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis
Maria Giovanna Danieli et al.
AUTOIMMUNITY REVIEWS (2009)
Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome
Baptiste Hervier et al.
JOINT BONE SPINE (2009)
Calcinosis cutis associated with amyopathic dermatomyositis: Response to intravenous immunoglobulin
Yeray Penate et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Anti-inflammatory actions of intravenous immunoglobulin
Falk Nimmerjahn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Pharmacokinetics of Immunoglobulin Administered via Intravenous or Subcutaneous Routes
Francisco A. Bonilla
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Respiratory Muscle Weakness with Dermatomyositis During Pregnancy: Successful Treatment with Intravenous Immunoglobulin Therapy
Yuji Nozaki et al.
JOURNAL OF RHEUMATOLOGY (2008)
Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis
Eizo Saito et al.
MODERN RHEUMATOLOGY (2008)
Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies
Sevim Barbasso Helmers et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Safety of intravenous immunoglobulin (IVIG) therapy
Uriel Katz et al.
AUTOIMMUNITY REVIEWS (2007)
Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy
B Chacko et al.
RENAL FAILURE (2006)
Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy
M Mosca et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
The long-term outcome of anti-Jo-1-positive inflammatory myopathies
M Späth et al.
JOURNAL OF NEUROLOGY (2004)
Intravenous immunoglobulin in autoimmune neuromuscular diseases
MC Dalakas
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Pregnancy outcome in adult-onset idiopathic inflammatory myopathy
CA Silva et al.
RHEUMATOLOGY (2003)
Interstitial lung disease in polymyositis and dermatomyositis
I Marie et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis - An open study with thirty-five adult patients
P Cherin et al.
ARTHRITIS AND RHEUMATISM (2002)
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis
MG Danieli et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Long-lasting effectiveness of intravenous immunoglobulin in a patient with inclusion-body myositis
BN Mukunda et al.
ANNALS OF INTERNAL MEDICINE (2001)
Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases
Y Sherer et al.
PHARMACOLOGY (2001)
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
HM Chapel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2000)
High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study
MC Walter et al.
JOURNAL OF NEUROLOGY (2000)
Share Paper
